The Westpoint Veterinary Group and Eville & Jones, a veterinary control provider, have joined forces to form Xperior Farm Health, which will bid for appointment as a Delivery Partner for bovine TB and other farm animal disease testing under AHVLA's Veterinary Delivery Partnership Programme.
The Delivery Partnership Programme, under which the AHVLA will cease to contract OVs directly and instead procure disease testing services from around ten Delivery Partners, is expected to roll out in the summer.
Eville & Jones is an experienced service provider in inspection and testing services in the fields of animal health, public health and animal welfare. The company employs more than 450 veterinary staff nationwide and already provides fully managed Official Veterinarian (OV) services to UK Competent Authorities.
Westpoint Veterinary Group is a specialist, farm-animal-only veterinary practice operating from 17 sites countrywide to provide farmers with specialist and locally based services. It is the largest veterinary group in the UK specialising in production animals, employing more than 50 veterinary surgeons.
Veterinary Director Phil Elkins MRCVS says the resources and experience of the two parent companies in both farmer-facing and back office dimensions make Xperior Farm Health well equipped to fulfil a Delivery Partner service expected by AHVLA. He said: "Our ambition is to provide an exemplary standard of accurate and trustworthy on-farm animal health testing services, where possible using subcontracted practices. If appointed, of course, these will be farmer friendly, provide an ongoing source of work and revenue to subcontractor Official Veterinarians, and represent excellent value for money to the taxpayer."
The app allows trainers to store and share medical records and treatment plans, identify horses and, with a Bio Thermo chip, monitor temperature non-invasively.
In Ireland, the Irish Horse Racing Board (IHRB) requires every yard keep a Blue Book which has to be submitted monthly. In the Blue Book, every medication given to every horse is recorded, with the amounts, the name of the medication and its batch number all written in by hand. EquiTrace enables a trainer to email the blue book information direct from their mobile phone.
Vincent O’Connor, senior vet at Sycamore Lodge Equine Hospital on the Curragh, Ireland, says he has found the app very easy to use and particularly appreciates the way it suggests stand down periods required for intraarticular medication, where injections into different joints require different numbers of days withdrawal before competition. The experience of John Oxx, whose winner I Know I Can was disqualified because of a positive test for TCA (triamcinolone acetonide) on 2 July 2020, is a case in point. Dr Lynn Hillyer, IHRB Chief Veterinary Officer and Head of Anti-Doping, stated that the minimum recommended stand down time for TCA would be 14 days but added that the stifle is a complex joint and can be associated with longer excretion times than might be expected.
Kevin Corley said: "Keeping a horse’s identity straight might seem a simple thing, but when you have a yard where staff and horses can change frequently and records are kept in the office, far away from the stables and fields where the horses are, it is not as easy as you think. I remember a time when I was called out to genetically test four two year olds, each valued at over €50,000 because their registration documents had been lost before they had been filed and no one knew which one was which."
EquiTrace has been in trials in Ireland, England, USA, Sweden and Italy and Kevin says every yard which has tested the app has kept it in operation.
EquiTrace is a subscription service, with a basic service for $1/€1 per month per horse and a premium subscription at $2/€2 per month per horse. A scanner available from EquiTrace as a one-time cost is required to operate the system, ranging in price from €250 to €400 or USA $350 to $550.
EquiTrace works with all ISO-compliant microchips but some of the service offerings are dependent on the type of chip in the horse.
EquiTrace is available on Apple and Google appstores. Establishments with over 200 horses can contact EquiTrace directly to arrange a subscription. Current clients include DK Weld in Ireland, Ramsey Farm and Three Chimneys Farm in Kentucky, USA, Kinsale Stud in the UK and Avantea in Italy.
For more information, visit: https://equitrace.app
The entertainer Michael Ball yesterday opened the final phase of Fitzpatrick Referrals' new ultra-hi-tech patient ward, which, according to the practice, will elevate animal care to a whole new level in the UK.
The ward boasts bacterial-resistant wipe-down wall coverings and floor surfaces with underground heating, and air conditioning optimised for high efficiency particulate air to minimise the possibility of infection.
Instead of gates or bars, the kennels have reinforced glass doors which permit a wide field of view for the animals and allow them to feel as much at home as possible. Each kennel has a space for medication and notes, and a "quick reference" daily guide is written on the glass door each morning to ensure continuity of care and ease of visibility for all. Each kennel has a radio and many are equipped with televisions to provide auditory and visual stimulation - creating a home from home experience for patients.
The practice says light is an important part of the "care package" offered in the luxury wards, and numerous windows and night time dimmers provide a diurnal rhythm to help comfort anxious animals and help those with separation anxiety to settle. Webcams are easily connected for remote viewing, and each and every patient is checked hourly by the 24 hour care team of ward assistants, fully qualified veterinary nurses, surgical interns, residents and senior clinicians.
Noel Fitzpatrick said: "I've always felt that people who love animals are generally great people, and they absolutely want to know that when their animal friend is away from home, especially if severely ill, that they are receiving round-the-clock care in the best facility imaginable. This in my head does not involve bars, so I have a "no bars" policy. I want the patient to be super-comfortable and not to feel threatened or "in prison", especially when some of them will have severe physical disability."
Michael Ball said: "I saw the Bionic Vet on television but I never thought I would find myself here. Noel has an extraordinary talent for healing and has built an amazing team who truly do care deeply about each and every one of these patients as if they were their own pets. They really do provide an unparalleled level of care. What Fitzpatrick Referrals has managed to do is truly remarkable. When I look at the level of hands-on care and compassion shown by all of team, I'm overwhelmed. I am hugely honoured to be associated with Fitzpatrick Referrals and what this practice stands for. The work which is happening here is benefitting the veterinary world and the human world - it's incredible."
After cutting the ribbon and declaring the new facility officially open, Michael Ball met with Dr Fitzpatrick for the 'see out consultation' for his dog, Freddie, who has been recovering after a major hip operation at the practice.
Merial Animal Health has been found in breach of the NOAH Code of Practice for literature promoting the wormer Ivomec Super.
In the literature, Merial stated that Closantel injection (Janssen Animal Health) was effective against flukes aged 9 weeks or older, when in fact, at the time the undated brochure was distributed, Closantel was effective against flukes aged 7 weeks or older.
Merial did not dispute the facts alleged: the company had relied on an out-of-date detailer. The NOAH Code of Practice Committee emphasised the need for members to ensure, when giving comparative data in promotions, that up-to-date data is used. The SPC of any authorised product can be viewed on the VMD's website.
The Committee did commend Merial Animal Health for taking corrective action within two days of notification by the Complainant.
NOAH encourages those interested in finding out more to read the full details of the Committee's rulings on the NOAH website at www.noah.co.uk/code.
The awards are designed to recognise successful implementation of quality improvement (QI) in veterinary practice, which can reduce avoidable errors, ensure practice is based on the best available evidence and, ultimately, save lives.
Entrants will need to demonstrate the impact that QI methods have had in their practice, such as increased efficiency, improved clinical or financial effectiveness, the development of a culture of continuous improvement, support in the use of evidence-based approaches, or a general bettering of excellence in care.
The awards are open to any member of a practice, including veterinary surgeons and nurses, practice managers, receptionists, locums, students, and more. You can also nominate a colleague, or vice versa.
Individual winners will get free tickets to an upcoming RCVS Knowledge event and be given a plaque pronouncing them a 'Knowledge Champion', while one team will scoop Knowledge’s 'Champion Practice' award.
RCVS Knowledge Executive Director Chris Gush said: "These awards are a great opportunity to celebrate the good work that is going on in practice and to highlight examples of quality improvement.
"I would encourage all – from quality improvement experts to QI beginners – to get involved and enter the awards."
The closing date to submit an application is 1st November 2018, allowing plenty of time for those interested in introducing a quality improvement initiative in their practice to do so and apply for the awards at a later date.
To learn more about QI and how you can get started, visit RCVS Knowledge's QI pages.
Alternatively, you can enter the awards here: https://knowledge.rcvs.org.uk/grants/available-grants/
With at least 65% of dogs and 39% of cats reported as overweight (1&2), the competition is designed to promote a healthy body shape for cats and dogs, and reward the hard work of pet owners and veterinary nurses for achieving and maintaining a pet’s healthy weight. It is open to patients that are starting out on a weight loss programme, those maintaining a healthy body shape following weight loss and even those who have always been a healthy weight and shape.
Six finalists will be selected from all the entries and invited to attend an awards lunch where the overall winner will be announced. All finalists will receive a £100 shopping voucher and the overall winner will receive a £1000 holiday voucher.
Caroline Burke, Weight Management Specialist at Royal Canin said: "The Healthy Weight Competition is the perfect opportunity for veterinary nurses and owners to tackle this serious disease and prevent it occurring.
"There are many health issues associated with an animal being overweight as well as affecting quality of life, longevity and the welfare of the pet. The Healthy Weight Competition is an ideal opportunity for practices to identify the overweight patients, enrol them on a weight loss programme and enter the competition. It also enables them to reward those cats and dogs who have maintained an ideal body shape and weight over a period of time."
The competition is open until 31st of August 2018.
For more information, visit: www.royalcaninhealthyweight.co.uk or contact your Veterinary Business Manager.
Reference
A major consultation of the National Occupational Standards required by veterinary nurses will take place throughout April 2010, giving veterinary nurses, employers and organisations the opportunity to ensure their ways of working are accurately reflected.
Lantra, the Sector Skills Council for environmental and land-based industries, is leading the UK wide project, which will lead to a revised list of skills needed for student and registered veterinary nurses to be able to do their job properly. Lantra is seeking individuals and organisations representing veterinary nursing and veterinary surgeons to participate in the online consultation and help ensure that National Occupational Standards fit modern business needs.
Lisa Jarvis, Industry Partnership Manager for veterinary nursing at Lantra and a RVN herself, said: "The National Occupational Standards identify the detailed knowledge, understanding, ability and experiences somebody needs to carry out their job effectively and they also form the basis of veterinary nursing qualifications. Industry input is critical for this review and so now is the time for you to go online and have your say."
Many employers and industry representatives from across the UK are supporting this extensive review.
Catherine Corden, a Veterinary Surgeon at the Northlands Veterinary Hospital, said: "I decided to get involved with this review so that I can actually contribute to the changes in the standards, instead of moaning about them afterwards. I think they are really important for industry as they maintain the standards of veterinary nurse training and I think industry should be getting involved with the upcoming consultation to help ensure these changes are relevant to the profession at large."
The online consultation will take place from Thursday 1 April to Friday 30 April, and will give all those interested parties the opportunity to review and comment on the standards for veterinary nurses.
Lisa said: "National Occupational Standards cannot be developed without your help. Only by working together can we ensure that the revised Standards will take into account any new business practices and make them fit for purpose and valued by employers."
To take part in the consultation and help industry get the most out of the skills system, visit www.lantra.co.uk/vn-nos. For more information about National Occupational Standards, email standardsandquals@lantra.co.uk, or call Lantra on 02476 858 424.
Norbrook Laboratories has launched a long-acting cattle bolus which it says will reduce the risk of Milk Fever.
According to the company, Calcitrace D3 is the first and only long-acting bolus to offer slow and fast releasing calcium to provide sustained calcium levels for 48 to 72 hours. In addition, Calcitrace D3 provides Magnesium, Phosphate and Vitamin D3 making it the most comprehensive bolus available.
Calcitrace D3 is smooth gelatin coated bolus with a rounded tip designed for easier administration. Norbrook says it is smaller than other boluses making it less likely to cause trauma on the orpharynx during administration.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Milk Fever is a common metabolic disorder in dairy cattle which generally affects older, high producing cows and is caused by a rapid decrease in calcium concentrations in the blood just before calving. It is estimated that 3-10% of cows are affected by Milk Fever with a cost of more than £200 per incident so it is crucial that farmers and vets reduce the risk as effectively as possible.
"Norbrook's new Calcitrace D3 bolus which should be administered just before calving, provides higher calcium blood levels during the critical 12 - 48 hour post calving period and provides sustained increased levels for well beyond 48 hours. With the addition of Magnesium, Phosphate and Vitamin D3, Calcitrace D3 provides additional protection against Milk Fever."
Andrew Hillan MVB MRCVS, Director of Veterinary Sciences at Norbrook, led the development of Calcitrace D3. He said: "The launch of Calcitrace D3 is another illustration of the very high quality of technical expertise that exists within our research and development department and underlines Norbrook's commitment to developing high quality and innovative products. It comes from a strong and exciting pipeline of new products which we will bring to the market over the next couple of years."
The RCVS Disciplinary Committee has refused an application for restoration to the Register by Mr Joseph Holmes, who was struck off in 2011 for serious professional misconduct associated with surgery he had carried out on a dog and two cats.
At a two-week Disciplinary Committee hearing that concluded on 14 January 2011, two separate complaints had been considered against Mr Holmes, formerly of Waltham Veterinary Clinic, Grimsby. These involved a total of 31 charges, of which 28 were found to amount to serious professional misconduct. Mr Holmes was found to have advised on and undertaken surgical procedures without sufficient clinical grounds or consideration of alternative treatment options; failed to obtain the informed consent of his clients; undertaken procedures outside his area of competence; failed to refer or discuss the option of referral to a specialist; and, failed to provide his patients with adequate pain relief.
The then-Committee directed Mr Holmes' name be removed from the Register, whereupon he appealed to the Privy Council, who dismissed his appeal on 22 December 2011, concluding that removal from the Register "was the only disposal which could properly reflect the primary need to serve both the interests of animal welfare and the reputation of the veterinary profession".
At the hearing last week the Committee considered several factors in relation to Mr Holmes' application for restoration. Although Mr Holmes gave assurances that he accepted the findings of the original hearing, this contrasted completely to the robust way in which he had challenged all of these at that hearing and the majority in his appeal. Mr Holmes had been off the Register for only 12 months - just over the minimum period before an application for restoral was permitted. The Committee took the view that the application was premature and was not satisfied that Mr Holmes truly appreciated the seriousness of the findings made against him.
In response to questions from the Committee, Mr Holmes showed deficiencies in his knowledge, such as not knowing all of the constituents of the human drug, Anadin Extra, in spite of having produced a record of continuing professional development (CPD) on analgesia and having prescribed it to a dog in the original complaint. He did not provide records of CPD for 2010, 2011 and 2012, and although recognising that working in isolation from the majority of his fellow practitioners had contributed to his failures, he had made very limited efforts to observe first-opinion veterinary practice.
The Committee accepted at face value Mr Holmes' statement that he had not worked as a veterinary surgeon whilst de-registered, and accepted that removal from the Register had had a profound effect on Mr Holmes and his family, including the sale of his practice. It noted that Mr Holmes produced only the testimonials previously submitted to the Privy Council, which were of limited scope.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "Having regard to all the factors set out above, the Committee regrets that it is not satisfied that the applicant is fit to be restored to the Register. Accordingly, the application is refused."
The modules, which are presented by US veterinary oncology specialists Dr Chad Johannes and Dr Sue Ettinger, are titled: ‘Mastering Mast Cell Tumours’, ‘Treating Canine Mast Cell Tumours’ and ‘Stelfonta’.
Each of the modules offer 30 minutes of bitesize, interactive CPD and are suitable for both veterinary surgeons and nurses.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: ‘We appreciate that for the majority of veterinary teams, finding time for CPD is pretty challenging at present. We therefore hope that the bitesize, on-demand format of these modules can provide the perfect solution, whilst still delivering high quality CPD’.
The modules can be accessed at: vet-uk.virbac.com/stelfonta/education
Virtual lunch and learn meetings are also available from Virbac Territory Managers.
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Organised by The Veterinary Edge in association with Simon Guiton of VETcpd, there will be three streams running throughout, with delegates able to gain 14 hours of CPD – or 16 if prepared to skip the tempting two-course lunches.
Speakers include:
Sessions run from 10am to 6pm on the first day (followed by a happy hour in the exhibition) and from 9am to 5.15pm on day two.
A two-day pass for vets costs £285 and a one-day pass £170 plus VAT.
The prices will increase after 31st August.
Passes include access to all three streams, a two-course lunch, other refreshments and the congress handbook, which will include summaries of the sessions.
Accommodation is available at the recently opened Courtyard by Marriott Hotel at Sandy Park; other hotels nearby include a Premier Inn and Holiday Inn Express.
www.theveterinaryedge.com.
Cat Henstridge, a small animal vet from South Yorkshire, has started a Facebook page to add the veterinary profession's voice to the campaign against the practice of puppy farming.
Cat said: "I write a blog on my website and recently touched on the subject of puppy farming. I was contacted by members of the 'PupAid' organisation and was shocked to learn that the veterinary community has no real public opinions on the subject. I found it really surprising that none of our professional bodies had spoken out, especially as we are supposed to be the bastions of animal welfare and see the consequences of poorly bred puppies all the time in our clinics."
"I am hoping the Facebook page will just be the start of a movement within the profession. Not only can we add our very powerful opinions to the discussion but this will be a way of driving the general public into our clinics to ask our advice, before they purchase a poor quality, sickly puppy and find themselves in trouble.
"Please join the page, add your stories about these dogs (we all have one!). At the risk of sounding cheesy, by coming together, we can really make a difference!"
The disease, which originally appeared in the late 1980s, was first detected in the UK in 2012. It affects the kidneys and has a 90% mortality rate.
The team at Anderson Moores, which has been leading research into this disease, wants to alert colleagues to these new cases, which have been confirmed since 1st January.
By comparison 18 cases were reported in the whole of 2018, 19 in 2019, and 47 in 2020.
The new cases have been identified in Herefordshire, Greater London and Exeter.
David Walker, American, RCVS and EBVS European specialist in small animal internal medicine, leads the team at Anderson Moores Vet Specialists and is the UK’s foremost authority on the disease. He said: “We’re very sad to confirm three new cases of CRGV already in 2021. Unfortunately, we find ourselves at the time of year when cases are most commonly identified.
"As well as these confirmed cases, we are awaiting results on a number of other dogs that have sadly been euthanised with suspected CRGV. It is understandably a worrying time of year for dog owners with regards to CRGV; however, the disease remains rare.
"We’re advising dog owners across the country to remain calm but vigilant and seek advice from their local vets if their dog develops unexplained skin lesions.”
Previous cases have been identified in Gloucestershire, Surrey, Derbyshire, Yorkshire, Lancashire, Cornwall, Devon and Staffordshire.
Mr Walker added: “If a dog becomes affected by CRGV, the best chance of recovery probably lies with early and intensive veterinary care which may be best provided at a specialist facility such as Anderson Moores.
“Treatment primarily revolves around intensive management of the acute kidney injury and is sadly only successful in around 10% of cases.
“However, the team here at Anderson Moores successfully treated a suspected case of CRGV in a Labrador Retriever. Molly was referred to our internal medicine team just before Christmas due to limb swelling and a deep, painful ulcerative lesion on one of her legs.
“Following four days’ intensive treatment, her condition started to improve and we began to cautiously hope she would survive the disease.
“Molly continued to slowly improve and, after two nerve-wracking weeks, she was discharged to continue her recovery at home."
To find out more about CRGV, visit www.andersonmoores.com and the Alabama Rot Research Fund at www.arrf.co.uk.
The RCVS Disciplinary Committee has dismissed charges of serious professional misconduct against a veterinary surgeon and former employee of Medivet (Watford).
Tomasz Nazimek, who qualified in Poland in 2001 before starting work in England in 2005, was alleged to have charged for the use of a blood pressure monitor during an exploratory laparotomy on a cat called Mitzi, whilst working at the Watford branch of Medivet in June 2009, when he knew, or ought to have known, it had not been used.
Despite his previous signed statements to the contrary, Mr Nazimek admitted at the outset of the hearing that no blood pressure monitor had in fact been used.
Accordingly, the Committee only had to establish whether Mr Nazimek himself had entered the fee for its use into Mitzi's records and, if so, whether this was done dishonestly.
The alleged incident came to light as a result of a covert investigation into Medivet conducted by the television production company Fulcrum TV in 2008/9, and subsequently commissioned by the BBC and broadcast in July 2010 as part of the Panorama programme 'It Shouldn't Happen at a Vets''.
Former dental nurse Alexandra Lee was employed by Fulcrum TV as an undercover reporter to work as a 'trainee veterinary nurse' at Medivet, in order to record audio and video footage of her experiences there.
The case against Mr Nazimek was based partly on a conversation overheard by Miss Lee following the operation on Mitzi, where she maintained that Guy Carter, a senior Medivet partner and veterinary surgeon, told Mr Nazimek (who was sitting at the practice computer typing up Mitzi's records) not to forget to include a fee for use of the blood pressure monitor.
However, Miss Lee's equipment had not recorded this exchange, due to a fault, and her video diary of that day's events was not put in evidence before the Committee. Miss Lee also accepted in evidence that she had not actually seen who entered the fee into the records, but had assumed it was Mr Nazimek.
Despite giving serious consideration to all of Miss Lee's evidence, the Committee found it of limited value.
The Committee considered the statements signed by Mr Nazimek, but prepared for him by the Medivet senior management in December 2009 and October 2010, which stated that he had used the monitor, consulted Mr Carter about charging for it and then added the fee himself.
The Committee also considered a third statement provided to the College (September 2011), in which Mr Nazimek recalled that Mr Carter had priced up the operation himself, but not asked for his input.
When questioned about the discrepancies in his statements, Mr Nazimek told the Committee that he had confused different operations and now knew his earlier statements to be wrong.
He indicated that he had been under pressure from his then employers to sign the statements, that his attempts to change them were ignored by Medivet's managing partners and that he was depressed and under stress at the time.
He was not told that the statements could be in relation to charges against him, or that he was entitled to legal advice when discussing them with his employers.
The Committee found Mr Nazimek's oral evidence to be persuasive, his manner open and his responses under cross-examination frank.
In the absence of satisfactory and reliable evidence to the contrary, and in view of supportive testimonials provided from his current employer and former colleagues as to his honesty and integrity, the Committee found Mr Nazimek's repeated assertion that he did not make a charge for the monitor "entirely plausible" and believed that he told the truth.
Nevertheless, the Committee emphasised that a charge for the monitor had been entered into the records when no such device had been used, which it regarded as unacceptable.
Speaking on behalf of the Committee, Chairman Professor Peter Lees said: "The Committee is not satisfied by the evidence so that it is sure that [Mr Nazimek] entered into the records for Mitzi a charge for the blood pressure monitor. [It] believes that [Mr Nazimek] told the truth when giving his evidence and the character references support his honesty.
"In these circumstances, it is not necessary to consider the charges further and the allegations against [Mr Nazimek] are dismissed."
The research also found that awareness of feline hypertension amongst cat owners is very low, with 80% of those questioned unaware that cats could have high blood pressure and nearly 20% believing that it was only an issue in humans.
Amongst those cat owners who are aware of feline hypertension, only 25% said they would consider asking their vet for a blood pressure check for their pet.
However, once made aware of the risks of high blood pressure, including blindness, seizures and kidney disease, 83% of owners said they would ask their vet for a blood pressure test for their cat.
Dr Natalie Borrill MRCVS, veterinary technical manager for cardionephrology at Ceva Animal Health, said: "Feline hypertension is a common condition in older cats; it is estimated that one in five cats from nine years of age are at risk of suffering from the condition3, but there is a low level of awareness amongst cat owners about this condition.
"By increasing awareness of the disease amongst owners, they will be more inclined to visit the vet with their older cat for regular blood pressure checks. It can also be very helpful for an owner to be present when blood pressure is measured because this can help reduce stress and anxiety in their cat. For more information cat owners can visit amadeus.vet."
The research results were released as part of Feline Hypertension Month, which is running until the end of May to raise awareness of hypertension and improve the detection and management of high blood pressure in cats. As part of the campaign, veterinary practices are being urged to measure their feline patients' blood pressure in cats over the age of seven.
Ceva says it will continue its Mercury Challenge throughout 2019 to increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension. Participating practices are given the opportunity to win diagnostic tools to help them identify feline hypertension.
For information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
References
Ceva Animal Health has introduced an improved version of Hepatosyl, its liver support supplement for horses.
Hepatosyl Plus for horses contains the same antioxidant ingredients as the original version but now also contains Silybin, the most active isomer of Silybum marianum (milk thistle)1.
According to Ceva, the addition of Silybin gives new Hepatosyl Plus a triple antioxidant approach to liver support to help neutralise free radicals within the liver. Free radicals are produced by hepatocyte mitochondria and cause oxidative damage to cell membranes, protein and DNA.
The company says Hepatosyl Plus's triple approach includes S-adenosylmethionine (SAMe), in a stable, pure and absorbable form, which is converted into the potent liver anti-oxidant glutathione and also helps to maintain bile flow; Vitamin E, which is well-known as a potent liver antioxidant, and Silybin, which works as an antioxidant by increasing cellular superoxide dismutase.
Hepatosyl Plus remains the only liver supplement to contain Vitamin K which is needed by the liver for the production of many essential clotting factors, such as factors II, VII, IX and X, making it ideally suited for pre and post anaesthetic liver support.
Ceva says an independent trial2 on horses with confirmed liver disease has demonstrated the benefits of Hepatosyl. Conducted by European Specialist in equine internal medicine Dr Tim Brazil, the trial involved seven horses of various ages and types. All animals were given Hepatosyl in addition to treatment with antimicrobials, corticosteroids, a low protein diet and vitamin B supplementation. Post SAMe supplementation tests revealed a notable reduction in raised liver enzymes, serum proteins and bile acids and the seven horses showed obvious improvements including better appetite, weight gain and demeanour.
For further product information contact Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
References1 Flatland B (2003) Botanicals, Vitamins and Minerals and the Liver2 Brazil T (2007) S-adenosylmethionine liver support supplement trial in horses
Pets at Home has announced the acquisition of the joint venture practice business, Vets4Pets, adding 93 stand-alone veterinary practices to the 116 in-store practices it already operates under the Companion Care brand.
Providing veterinary and grooming services to consumers is seen as the way for the retailer to overcome competition from the Internet.
Nick Wood, CEO of Pets at Home said: "The expansion of our veterinary business is a key element of our growth strategy for Pets at Home, providing additional services to our customers within our stores or close to our customers' homes. The acquisition of Vets4Pets is an important step in the delivery of this strategy. Vets4Pets is highly complementary to Companion Care, sharing fundamental beliefs and values, and is an excellent strategic fit for Pets at Home. I am delighted that Peter Watson has agreed to stay with the business. His knowledge and experience will be invaluable as we continue to build our veterinary business with both stand-alone and in-store practices. He will work closely with Jane Balmain, the Managing Director of our Companion Care business as we integrate the two businesses."
Peter Watson, Founder and CEO of Vets4Pets said: "Pets at Home holds a unique place in the retail landscape, built on a strong identity and a real passion for people and pets. It is clear to me that Nick and his team have a similar vision for their veterinary business. I'm delighted to be working with Nick to continue to expand the veterinary business by offering attractive joint venture opportunities for vets in stand alone locations to complement the offering in Pets at Home stores."
Companion Care MD, Jane Balmain added: "Companion Care and Vets4Pets each enjoy a strong reputation among both vets and customers. Both businesses have a common business model, offering joint venture partnerships with vets. I am looking forward to working alongside Peter as we bring the businesses together, continue to expand our joint venture partnerships and accelerate our growth."
Vets4Pets' UK operational centre will remain in the East Midlands, with its support functions being split between Companion Care's operation in Oxfordshire and Vets4Pets' Guernsey office.
The company has completed a health hazard assessment which concluded that any risk to animal and human health is likely to be low and no greater than expected for this product under normal conditions, as described on the product labelling.
The recall is for the following batches only:
Batch Numbers:
0265-900302-900246-900112-900295-909053-919103-91
Norbrook Laboratories Ltd is contacting veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Gary Mckee on +44 2830 264435 or email gary.mckee@norbrook.co.uk
Jack Fellows, Elanco swine sales leader, said: "With the potential zinc oxide restrictions coming into place next year, it’s crucial that vets work with their farmers to start trialling alternative PWD prevention strategies now, while the use of zinc is still permitted.
“Keeping PWD at bay going forward will require a multifaceted approach to piglet management. Gradually reducing the level of zinc oxide, while simultaneously incorporating alternative preventive techniques, will reduce the likelihood of problems arising during this transition.
“It’s far more convenient to have the vaccine in a 200 head dose, rather than the current pack size that offers 50 treatments. This will greatly cut down the time required to dilute and stabilise multiple individual packs, while helping to minimise any margin of error during administration."
Research has shown over 90% of farmers1 would head to their vet as the first port of call when it comes to advice on treating PWD.
“It’s crucial that vets are aware of all the preventive tools and options for managing the disease as over half of farmers surveyed2 also said they would treat PWD with antibiotics, which is obviously something we’re trying to steer away from as an industry, and why vaccines play such an important role going forwards.
“The Coliprotec vaccine is proven to prevent against these issues, delivering healthy pigs that reach a heavier market weight up to 7 days earlier3, while substantially reducing the in-nursery use of antibiotic treatments."
To mark the launch of the new 200 dose pack size, Elanco is offering veterinary practices the chance to buy five packs for the price of four, a total of 1000 doses, through their wholesaler.
For more information, contact Jack Fellows at jack_michael.fellows@elancoah.com or call 07771 798157.
Louise is an RCVS and EBVS European Specialist in Veterinary Anaesthesia and Analgesia, and a Past President of the Pain Medicine Section Council at the Royal Society of Medicine. She has also been an invited examiner on the European Diploma examination and a Treasurer of the Association of Veterinary Anaesthetists. She has headed the anaesthesia team at Davies since 2007.
Her tips are:
Richard, who works at North Downs Specialist Referrals (NDSR), graduated from the Royal Veterinary College in 2003.
While working in general practice, he developed an interest in ophthalmology and undertook an internship in the field at the Animal Health Trust in 2013.
Richard said: "Watching cataract surgery for the first time as a student, I was amazed it could be performed through such tiny incisions and an artificial lens could be placed inside the eye.
"My grandmother had cataract surgery around this time, followed later by corneal transplants when I was a recently qualified vet, and this further sparked my interest.
"I was very fortunate during my time in general practice to be able to attend an excellent one-year modular course, with an inspiring teacher, and also to spend some time with two specialist ophthalmologists at NDSR.
"These experiences made me realise it was time to make the leap and try to become a specialist. It was quite a daunting step, but one I’ve never regretted."
Following his internship, Richard undertook a three-year specialist training programme in comparative ophthalmology at the Queen Mother Hospital for Animals, studying towards the European College of Veterinary Ophthalmology Diploma.
After the successful completion of his training, he remained at the RVC as a clinician for a further year before joining the team at NDSR in July 2018.
Richard says he is now looking forward to further developing ophthalmology services at NDSR, alongside RCVS and American specialist James Histed: "I have already been discussing with James how we can develop the ophthalmology service, with new equipment and treatment options.
"We will soon be taking delivery of a new Zeiss operating microscope, which will have video facilities and eyepieces for an assistant. This will help us to perform more complex surgical procedures, and also help in teaching our interns and visitors to NDSR."
For more information, visit www.ndsr.co.uk.
At the hearing, Dr Crawford made no admissions to the charges against him which involved allegations of: failing to provide adequate and appropriate care; failing to provide adequate clinical histories to another practice in respect of several animals; failing to treat fellow veterinary professionals and other members of staff from another practice with courtesy and respect; failing to maintain adequate clinical records; failing to have in place Professional Indemnity Insurance or equivalent arrangements; and, failing to respond to reasonable requests from the RCVS.
Dr Crawford’s representative drew the Committee’s attention to the fact that Mr Crawford was 71 years old, had no previous disciplinary findings against him and had now ceased practising, including closing his practice premises and notifying his previous clients of the closure.
His representative confirmed that Mr Crawford was fully aware that if his application was accepted, he would no longer be able to practise as a veterinary surgeon or identify as a veterinary surgeon. The Committee also noted that the RCVS had consulted with the complainants who were satisfied with the case being disposed of in this way.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “Having weighed the public interest in a hearing with the registrant’s interests, the Committee determined that this is not a case in which the public interest required there to be a full hearing. Protection of the welfare of animals would also not be further served by a full hearing. The Committee decided to accede to the respondent’s application.
"The Committee considered that the adjournment on undertakings served to protect the public interest, confidence in the profession and the welfare of animals.
"The Committee carefully considered the detail of the undertakings. It decided, after due consideration that it would accept the respondent’s undertakings in the terms offered and signed."
The Committee also heard that if Dr Crawford were to apply to re-join the Register at a future point, then the adjourned case would be re-opened and a full, public Disciplinary Committee hearing would be held.
The full documentation for the case can be found at: www.rcvs.org.uk/disciplinary
MSD Animal Health has announced the European launch of Activyl, a novel flea and tick treatment containing indoxacarb, an active that is new to animal health and which - uniquely - is activated by flea metabolism.
Activyl is licensed to treat and prevent flea infestations in cats and dogs. Activyl Tick Plus (indoxacarb + permethrin) controls fleas and ticks in dogs.
According to MSD, Activyl is the first flea control product to use metabolic activation, or bioactivation, to kill fleas. It is a topical, once-a-month ectoparasiticide containing indoxacarb, an agent that, because it is new, has no known flea resistance. Following application, indoxacarb is taken up by fleas where it is converted into an active metabolite. This metabolite causes fleas to stop feeding and they die within hours. Unlike insects, mammals mainly convert indoxacarb into non-toxic metabolites so they are not exposed to the active insecticide.
MSD says that Activyl also disrupts the flea life cycle by inhibiting the development of flea larvae. This aids in the environmental control of flea infestations and helps prevent re-infestation for up to four weeks. It may also be used as part of a treatment strategy for flea allergy dermatitis. In laboratory and field studies, Activyl has been shown to have a fast initial and persistent speed of kill that results in greater than 95% efficacy in preventing flea infestation for a full four weeks (MSD Animal Health, data on file).
Dr. Linda Horspool, BVMS, PhD, DipECVPT, MRCVS, global technical director for companion animal pharmaceuticals and parasiticides at MSD Animal Health said: "This innovation is the first time that a pro-insecticide, requiring activation by flea enzymes to produce a highly insecticidal active metabolite that kills adult and developing stages of fleas in the immediate environment of treated pets, has been used to provide flea control in dogs and cats."
Dispensed in clear pipettes that can easily be opened with one hand, Activyl is fragrance-free, dries quickly and remains effective following shampooing, swimming and exposure to sunlight. Seven sizes are available to treat small to extra-large dogs (five sizes) and small and large cats (two sizes). The product is approved for use in puppies and kittens from eight weeks of age.
Activyl Tick Plus is exclusively for dogs. In addition to indoxacarb, Activyl Tick Plus contains permethrin, an acaricide with proven efficacy against ticks. Studies have shown that Activyl Tick Plus kills more than 90% of common tick species including those known to carry such diseases as Babesiosis, Ehrlichiosis and Lyme disease (MSD Animal Health, data on file).
Once applied, Activyl Tick Plus kills fleas for up to four weeks and kills and repels ticks for three to five weeks. It remains effective following swimming and exposure to rain or sunlight. The product is also provided in easy to use applicators in a variety of different sizes and has been approved for use in puppies from as young as eight weeks of age. Activyl Tick Plus is not for use on cats.
David Hallas, BVSc and companion animal franchise leader at MSD Animal Health said: "Both products will be available strictly through licensed veterinarians, benefiting dogs and cats and their owners by controlling fleas in an innovative way."
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
The solution, which Virbac says can also help eliminate bad breath, has been given a fresh new blue colour as well as a new bottle with a more contemporary design.
Claire Lewis, Junior Product Manager at Virbac, said: "Vet Aquadent is tried and trusted by many pet owners and relied upon for the contribution it makes to maintaining oral and dental health in dogs and cats.
"Blue is a popular colour in the veterinary dental sector so we wanted to bring Vet Aquadent in line with other related products to help ensure that it is instantly recognisable, both to existing and new users.
"It sits alongside the other products in our ‘at-home’ veterinary dental range, including our Enzymatic toothpastes which inhibit bacterial growth and our highly palatable VeggieDent chews, which are available in four sizes."
"Given the number of pets suffering from periodontal disease, encouraging pet owners to adopt an effective preventative care regime is a simple way for veterinary practices to encourage responsible pet ownership and, in so doing, generate a useful revenue stream from product sales."